Colobreathe® (colistimethate sodium)

This information is only for patients who have been prescribed Colobreathe® (colistimethate sodium) Turbospin® inhaler

Colobreathe® contains colistimethate sodium, a type of antibiotic called a polymyxin.

Colobreathe® is used to control persistent lung infections caused by the bacterium Pseudomonas aeruginosa in adult patients and children aged 6 years and older with cystic fibrosis. Pseudomonas aeruginosa is a very common bacterium that infects nearly all cystic fibrosis patients at some time during their lives. Some people will get this infection whilst very young but for others it will be much later. If this infection is not properly controlled it will cause damage to the lungs.

Colobreathe® works by destroying the bacterial cell membrane, having a lethal effect on them.

For more information please refer to the Patient Information Leaflet.

Colobreathe® (colistimethate sodium) Patient Guide and Instructions for Use

Understanding your Patient Information Leaflet

Within the original packaging of all regulated medicines, you will find an important document called the Patient Information Leaflet. We recommend you read this document carefully and keep it for future reference.

The Patient Information Leaflet gives you key information to help you get the desired results from your medicine. Reading the Patient Information Leaflet is designed to supplement – not replace – discussions with your doctor, pharmacist or other healthcare professional about the medication. 

If for any reason your medicine has not come with this leaflet, you can ask for one from your pharmacist. Patient Information Leaflets are also available to download from the HPRA website.